Francisella tularensis genomics and proteomics

被引:43
|
作者
Titball, Richard W. [1 ]
Petrosino, Joseph F.
机构
[1] Def Sci & Technol Lab, Salisbury SP4 0JQ, Wilts, England
[2] London Sch Hyg & Trop Med, Dept Infect & Trop Med, London WC1E 7HT, England
[3] Baylor Coll Med, Human Genome Sequencing Ctr, Dept Mol Virol & Microbiol, Houston, TX 77030 USA
关键词
Francisella tularensis; genomics; proteomics; genome sequence; immunoproteomics; evolution;
D O I
10.1196/annals.1409.015
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The availability of the genome sequences of different strains of Francisella tularensis is having a major impact on a wide range of research projects, from understanding the biology of this organism to devising vaccines and diagnostics. Comparative genomics and molecular typing methods suggest that the four different subspecies of F. allarensis are genetically distinct groups. Although there is a high degree of nucleotide identity between strains, there are numerous DNA rearrangements. IS elements appear to have played a major role in these chromosomal rearrangements. The different subspecies of F tularensis appear to have evolved by vertical descent from a common ancestor, probably F. tularensis subspecies novicida. Comparative genomic and proteomic studies have revealed possible reasons for the different virulence of different strains and a range of candidate virulence genes have been identified including those located on the Francisella pathogenicity island. Proteomic studies have identified proteins which are produced at elevated levels in vivo, and proteins which are recognized by immune or convalescent sera. These proteins might be exploited as components of vaccines or diagnostic systems.
引用
收藏
页码:98 / 121
页数:24
相关论文
共 50 条
  • [1] Francisella tularensis vaccines
    Griffin, Kate F.
    Oyston, Petra C. F.
    Titball, Richard W.
    [J]. FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY, 2007, 49 (03): : 315 - 323
  • [2] FRANCISELLA TULARENSIS - REVIEW
    Cieslik, Piotr
    Knap, Jozef
    Bielawska-Drozd, Agata
    [J]. POSTEPY MIKROBIOLOGII, 2018, 57 (01): : 58 - 67
  • [3] FRANCISELLA-TULARENSIS
    EVANS, ME
    [J]. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 1985, 6 (09): : 381 - 383
  • [4] Francisella tularensis aortitis
    Briere, M.
    Kaladji, A.
    Douane, F.
    Breux, J. P.
    Touroult-Jupin, P.
    Boisset, S.
    Edouard, S.
    Biron, C.
    Boutoille, D.
    [J]. INFECTION, 2016, 44 (02) : 263 - 265
  • [5] Francisella tularensis meningitis
    Contentin, L.
    Soret, J.
    Zamfir, O.
    Gontier, O.
    Lherm, T.
    Hamrouni, M.
    Ouchenir, A.
    Monchamps, G.
    Kalfon, P.
    [J]. MEDECINE ET MALADIES INFECTIEUSES, 2011, 41 (10): : 556 - 558
  • [6] Francisella tularensis endocarditis
    Tancik, CA
    Dillaha, JA
    [J]. CLINICAL INFECTIOUS DISEASES, 2000, 30 (02) : 399 - 400
  • [7] Francisella tularensis, Portugal
    de Carvalho, Isabel Lopes
    Escudero, Raquel
    Garcia-Amil, Cristina
    Falcao, Helena
    Anda, Pedro
    Nuncio, Maria Sofia
    [J]. EMERGING INFECTIOUS DISEASES, 2007, 13 (04) : 666 - 667
  • [8] Francisella tularensis aortitis
    M. Briere
    A. Kaladji
    F. Douane
    J. P. Breux
    P. Touroult-Jupin
    S. Boisset
    S. Edouard
    C. Biron
    D. Boutoille
    [J]. Infection, 2016, 44 : 263 - 265
  • [9] Francisella tularensis:: an overview
    Titball, RW
    Sjöstedt, A
    [J]. ASM NEWS, 2003, 69 (11): : 558 - +
  • [10] Francisella tularensis vaccines
    Oyston, Petra C. F.
    [J]. VACCINE, 2009, 27 : D48 - D51